These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 17558893)

  • 1. Maintained malnutrition produces a progressive decrease in (OPG)/RANKL ratio and leptin levels in patients with anorexia nervosa.
    Muñoz-Calvo MT; Barrios V; García de Alvaro MT; Lefort M; Méndez-Dávila C; Argente J; de la Piedra C
    Scand J Clin Lab Invest; 2007; 67(4):387-93. PubMed ID: 17558893
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Higher levels of s-RANKL and osteoprotegerin in children and adolescents with type 1 diabetes mellitus may indicate increased osteoclast signaling and predisposition to lower bone mass: a multivariate cross-sectional analysis.
    Tsentidis C; Gourgiotis D; Kossiva L; Doulgeraki A; Marmarinos A; Galli-Tsinopoulou A; Karavanaki K
    Osteoporos Int; 2016 Apr; 27(4):1631-1643. PubMed ID: 26588909
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The relationship between serum levels of estradiol and osteoprotegerin in patients with anorexia nervosa.
    Ohwada R; Hotta M; Sato K; Shibasaki T; Takano K
    Endocr J; 2007 Dec; 54(6):953-9. PubMed ID: 17998762
    [TBL] [Abstract][Full Text] [Related]  

  • 4. RANKL:osteoprotegerin ratio and bone mineral density in children with untreated juvenile dermatomyositis.
    Rouster-Stevens KA; Langman CB; Price HE; Seshadri R; Shore RM; Abbott K; Pachman LM
    Arthritis Rheum; 2007 Mar; 56(3):977-83. PubMed ID: 17328075
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Association between low bone mass and the serum RANKL and OPG in patients with nephrolithiasis.
    Mansour A; Aboeerad M; Qorbani M; Hashemi Taheri AP; Pajouhi M; Keshtkar AA; Larijani B; Mohajeri-Tehrani MR; Ganji MR
    BMC Nephrol; 2018 Jul; 19(1):172. PubMed ID: 29996796
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Relation of RANKL and OPG Levels with Bone Resorption in Patients with Acromegaly and Prolactinoma.
    Ozer FF; Dagdelen S; Erbas T
    Horm Metab Res; 2018 Jul; 50(7):562-567. PubMed ID: 29895074
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Selected pro-inflammatory cytokines, bone metabolism, osteoprotegerin, and receptor activator of nuclear factor-kB ligand in girls with anorexia nervosa.
    Ostrowska Z; Ziora K; Oświęcimska J; Marek B; Świętochowska E; Kajdaniuk D; Strzelczyk J; Cieślicka A; Wołkowska-Pokrywa K; Kos-Kudła B
    Endokrynol Pol; 2015; 66(4):313-21. PubMed ID: 26323468
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Relationships among serum receptor of nuclear factor-kappaB ligand, osteoprotegerin, high-sensitivity C-reactive protein, and bone mineral density in postmenopausal women: osteoimmunity versus osteoinflammatory.
    Nabipour I; Larijani B; Vahdat K; Assadi M; Jafari SM; Ahmadi E; Movahed A; Moradhaseli F; Sanjdideh Z; Obeidi N; Amiri Z
    Menopause; 2009; 16(5):950-5. PubMed ID: 19387415
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Relationships between OPG, RANKL, bone metabolism, and bone mineral density in biliary atresia.
    Honsawek S; Chaiwatanarat T; Vejchapipat P; Chongsrisawat V; Thawornsuk N; Poovorawan Y
    Pediatr Surg Int; 2009 Mar; 25(3):261-7. PubMed ID: 19184056
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The relationship between chemerin, bone metabolism, the RANKL/RANK/OPG system, and bone mineral density in girls with anorexia nervosa.
    Ostrowska Z; Morawiecka-Pietrzak M; Pluskiewicz W; Świętochowska E; Strzelczyk J; Gołąbek K; Gaździcka J; Ziora K
    Endokrynol Pol; 2022; 73(1):26-34. PubMed ID: 35119086
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Relationships between insulin-like growth factor-I (IGF-I) and OPG, RANKL, bone mineral density in healthy Chinese women.
    Zhao HY; Liu JM; Ning G; Zhao YJ; Chen Y; Sun LH; Zhang LZ; Xu MY; Chen JL
    Osteoporos Int; 2008 Feb; 19(2):221-6. PubMed ID: 17703270
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The effect of leptin replacement on parathyroid hormone, RANKL-osteoprotegerin axis, and Wnt inhibitors in young women with hypothalamic amenorrhea.
    Foo JP; Polyzos SA; Anastasilakis AD; Chou S; Mantzoros CS
    J Clin Endocrinol Metab; 2014 Nov; 99(11):E2252-8. PubMed ID: 25148234
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Serum osteoprotegerin in adolescent girls with anorexia nervosa.
    Misra M; Soyka LA; Miller KK; Herzog DB; Grinspoon S; De Chen D; Neubauer G; Klibanski A
    J Clin Endocrinol Metab; 2003 Aug; 88(8):3816-22. PubMed ID: 12915674
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Imbalance of the osteoprotegerin/RANKL ratio in bone marrow microenvironment after allogeneic hemopoietic stem cell transplantation.
    Ricci P; Tauchmanova L; Risitano AM; Carella C; Mazziotti G; Lombardi G; Colao A; Rotoli B; Selleri C
    Transplantation; 2006 Dec; 82(11):1449-56. PubMed ID: 17164716
    [TBL] [Abstract][Full Text] [Related]  

  • 15. RANKL/RANK/OPG system and bone status in females with anorexia nervosa.
    Ostrowska Z; Ziora K; Oświęcimska J; Swiętochowska E; Szapska B; Wołkowska-Pokrywa K; Dyduch A
    Bone; 2012 Jan; 50(1):156-60. PubMed ID: 22001124
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Serum RANKL, osteoprotegerin (OPG) and RANKL/OPG ratio in children with systemic lupus erythematosus.
    Ali R; Hammad A; El-Nahrery E; Hamdy N; Elhawary AK; Eid R
    Lupus; 2019 Sep; 28(10):1233-1242. PubMed ID: 31403902
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Anorexia nervosa, osteoporosis and circulating leptin: the missing link.
    Legroux-Gérot I; Vignau J; Biver E; Pigny P; Collier F; Marchandise X; Duquesnoy B; Cortet B
    Osteoporos Int; 2010 Oct; 21(10):1715-22. PubMed ID: 20052458
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Bone metabolism, osteoprotegerin, receptor activator of nuclear factor-κB ligand and selected adipose tissue hormones in girls with anorexia nervosa.
    Ostrowska Z; Ziora K; Oświęcimska J; Świętochowska E; Marek B; Kajdaniuk D; Wołkowska-Pokrywa K; Kos-Kudła B
    Endokrynol Pol; 2014; 65(1):33-9. PubMed ID: 24549600
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Bone mineral density in egyptian children with juvenile idiopathic arthritis: possible correlation to serum RANKL / osteoprotegerin (OPG) ratio and OPG gene polymorphisms.
    Eid R; Abdelsalam M; Fathy AA; Abolenein HM; Elmarghany EB; El-Hanafy AA; Hamdy N; Abd-Elmagid DS; Niazy NA; Abd-El Ghaffar DM
    Pediatr Rheumatol Online J; 2023 Jun; 21(1):58. PubMed ID: 37328895
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Serum osteoprotegerin and receptor activator of nuclear factor-kappaB ligand (RANKL) concentrations in allogeneic stem cell transplant-recipients: a role in bone loss?
    Kananen K; Volin L; Laitinen K; Ruutu T; Välimäki MJ
    Osteoporos Int; 2006; 17(5):724-30. PubMed ID: 16437190
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.